United Spirits Ltd delivers stellar Q2 FY2025 performance with 12% revenue growth and 18% profit surge. Discover why analysts are bullish on India's leading liquor stock and what it means for your portfolio.
Hindustan Unilever's ice cream business gets NCLT approval for demerger. Discover what this means for investors, employees, and the future of brands like Magnum and Kwality Wall's.
Swiggy's stock price jumps 4% following impressive Q2 earnings. Discover key financial metrics, broker recommendations, and whether you should invest in the food delivery giant.
Orkla India's highly anticipated IPO shows promising grey market premium signals. Get complete details on subscription status, price band, and expert review before investing.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Gold prices on MCX witnessed significant decline, falling near ₹1.21 lakh per 10 grams as US dollar strengthened. Silver prices also dropped 0.5% in today's trading session. Get latest commodity market updates.
Studds Accessories IPO creates buzz with strong grey market premium. Complete analysis of price band, financials, and expert recommendations for potential investors.
Get expert stock market insights! Chandan Taparia shares his top 3 buy recommendations and stocks to avoid in today's volatile trading session. Discover trading strategies for immediate action.
Indian stock markets poised for positive opening following strong Asian cues. Get expert analysis on Nifty 50, Sensex performance, key support levels, and global market trends affecting your investments.
Mumbai markets expert Vaishali Parekh reveals three stocks poised for significant growth. Discover her technical analysis and price targets for today's trading session.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Indian markets poised for strong start as Gift Nifty surges, Asian markets hit record highs, and global factors align favorably. Discover the 8 key developments shaping today's trading session.
Get expert stock recommendations from MarketSmith India for October 31 trading session. Discover which stocks are showing strong technical breakout patterns and momentum signals in today's volatile market.
Major Indian companies including Maruti Suzuki, Vedanta, BEL, BPCL, and GAIL are announcing their Q2 FY2025 earnings today. Get insights on expected performance, key financial indicators, and market impact analysis.
Expert analyst Sumeet Bagadia reveals 5 breakout stocks with strong technical indicators for immediate buying. Discover which shares are poised for significant growth in today's volatile market.
Discover the hottest stock recommendations from market guru Raja Venkatraman as he shares his expert analysis on D-Mart, Persistent Systems, Laurus Labs and more for explosive growth potential.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
India Securities delivers stellar Q2 performance with 42% revenue surge and declares second interim dividend, continuing its 900% growth journey that created massive wealth for investors.
Lenskart's highly anticipated IPO gains strong momentum as marquee investors pour ₹3,268 crore into the eyewear disruptor. Discover key details about anchor allocation, investor interest, and what this means for the retail public issue.
SEBI introduces sweeping reforms for index derivatives, setting new criteria for stock exchanges. Discover how these changes will impact market participation and risk management.
Market regulator SEBI announces concrete timeline for derivatives restructuring on banking indices to deepen sector representation and enhance market efficiency. Key changes coming to Bank Nifty, Bankex, and Finnifty.
3i Infotech's rights issue receives overwhelming investor response, oversubscribing by 1.47 times and successfully raising ₹64.10 crore to fuel growth initiatives.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Indian rupee tumbles to 88.69 against US dollar as Federal Reserve's aggressive tone and weak domestic markets create perfect storm for currency decline. Key factors and market impact analyzed.
The Studds Accessories IPO witnessed strong investor appetite on its debut day, getting subscribed 1.54 times. Discover the latest GMP, subscription breakdown, and what makes this helmet manufacturer a hot pick among investors.
US markets hover near all-time peaks as investors balance Big Tech earnings optimism with US-China trade negotiations. Discover how major indices performed and what's driving Wall Street's bullish sentiment.
US stock markets faced downward pressure as Federal Reserve signals and corporate earnings created uncertainty. Discover which sectors struggled and why analysts remain cautious about near-term trends.
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Discover how a little-known small-cap stock under ₹50 delivered staggering 600% returns in just five years and why analysts are watching it closely now.
Jio BlackRock's digital-first mutual fund strategy signals major shift in India's investment landscape as online platforms dominate distribution with AI-powered solutions.
Agrochemical major Sharda Cropchem delivers stellar Q2 performance with massive profit growth and strong revenue increase, showcasing robust demand in global markets.
Indian stock markets witnessed sharp selloff as fading Fed rate cut hopes and rising US bond yields sparked global risk aversion. Discover 10 crucial insights from today's trading session.
SafeCurе Services' SME IPO maintains steady investor interest with 1.2x subscription on Day 2. Check latest GMP, price band details, and company fundamentals in this comprehensive analysis.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
